ArticleCancer gene therapy2006

Growth inhibition efficacy of an adenovirus expressing dual therapeutic genes, wild-type p53, and anti-erbB2 ribozyme, against human bladder cancer cells.

A Irie et al.PubMed ↗Publisher ↗

No numbers read from the abstract.